![Mark Gilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Gilbert
Chief Tech/Sci/R&D Officer at
JW (CAYMAN) THERAPEUTICS CO. LTD
Profile
Mark J.
Gilbert is currently Director at Inceptor Bio LLC since 2022.
Dr. Gilbert is Chief Medical Officer at JW Therapeutics (Shanghai) Co., Ltd. since 2020.
Dr. Gilbert is Chief Medical Officer at JW (Cayman) Therapeutics Co. Ltd. Formerly, Dr. Gilbert was Senior Medical Director at Immunex Corp.
Dr. Gilbert was Independent Director at Silicon Therapeutics, Inc. from 2019 to 2021.
Dr. Gilbert was Independent Director at Indaptus Therapeutics, Inc. from 2021 to 2026.
Dr. Gilbert was Independent Director at Silicon Insite, Inc. from 2019 to 2021.
Dr. Gilbert was Vice President & Head-Global Clinical Development at Bayer Schering Pharma AG.
Dr. Gilbert was Vice President & Head-Global Clinical Development at Bayer HealthCare Pharmaceuticals, Inc. Dr. Gilbert was Vice President & Head-Global Medical Development at Berlex Pharmaceuticals, Inc. Dr. Gilbert was Executive Vice President-Research & Development at Acepodia Biotechnologies, Ltd. from 2019 to 2022.
Dr. Gilbert was Chief Medical Officer & Senior Vice President at Juno Therapeutics, Inc. from 2013 to 2020.
Education includes undergraduate degree from the University of Iowa and doctorate from the University of Iowa Carver College of Medicine.
Mark Gilbert active positions
| Companies | Position | Start |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Chief Tech/Sci/R&D Officer | - |
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | 2022-10-31 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Chief Tech/Sci/R&D Officer | 2020-02-29 |
Former positions of Mark Gilbert
| Companies | Position | End |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Director/Board Member | 2026-02-25 |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Develops novel, targeted, allogeneic cell therapies to treat cancers | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Director/Board Member | 2021-04-30 |
Silicon Therapeutics, Inc. | Director/Board Member | 2021-04-30 |
| JUNO THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Training of Mark Gilbert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Manufactures, markets, and researches therapeutic products | Health Technology |
Bayer Schering Pharma AG
 Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Berlex Pharmaceuticals, Inc. | |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
University of Iowa Carver College of Medicine
 University of Iowa Carver College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Develops novel, targeted, allogeneic cell therapies to treat cancers | Health Technology |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Indaptus Therapeutics, Inc.
 Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Silicon Therapeutics, Inc. |
- Stock Market
- Insiders
- Mark Gilbert
